vobarilizumab (ALX-0061) - Sanofi
Ablynx: Corporate Presentation (Ablynx) - Nov 14, 2014 - Anticipated initiation of P2b trial for rheumatoid arthritis in 2015; Anticipated data from P2 trial for rheumatoid arthritis in 2016 
Anticipated P2 data • Anticipated trial initiation date Rheumatoid Arthritis
http://www.ablynx.com/wp-content/uploads/2014/11/Ablynx-Corporate-presentation_November-2014_FINAL.pdf
 
Nov 14, 2014
 
.
 
ef53fae9-e150-4820-b31c-a1710ee01369.jpg